3mensio Workstation is standalone medical-image analysis software for advanced visualization and quantitative analysis of cardiovascular structures. It supports CT, X-ray angiography, and two- and three-dimensional ultrasound DICOM data for planning and sizing cardiovascular interventions, postoperative evaluation, coronary measurements, and calcium scoring.
Clinical role
Image post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Heart/Cardiovascular
Key limitation
Not publicly available
Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Imaging and anatomyRadiological images; modality varies or is not specified in FDA list · Heart/Cardiovascular
Workflow roleImage post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
Required inputVendor-independent CT, X-ray angiography, and two- or three-dimensional ultrasound data in DICOM format.
Output and human actionAdvanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
3mensio Workstation is standalone medical-image analysis software for advanced visualization and quantitative analysis of cardiovascular structures. It supports CT, X-ray angiography, and two- and three-dimensional ultrasound DICOM data for planning and sizing cardiovascular interventions, postoperative evaluation, coronary measurements, and calcium scoring.
Image post-processing software that views CT/X-Ray angiographic and ultrasound images, segments cardiovascular structures, and analyzes and quantifies them for diagnostics in cardiology and radiology, including pre-operational planning and sizing for cardiovascular interventions and surgery.
Exact FDA submission
Checked 2026-11-14
Packet wording: "3mensio Workstation is an image post-processing software package for advanced visualization and analysis for diagnostics in the field of cardiology and radiology" … "offers functionality to view CT/X-Ray angiographic and ultrasound images, to segment cardiovascular structures in these images and to analyze and quantify these cardiovascular structures". Read from the exact FDA decision document on 2026-11-14.
The FDA 510(k) summary reports non-clinical verification and validation but no independent clinical performance study or comparative clinical endpoint.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The FDA 510(k) summary reports non-clinical verification and validation but no independent clinical performance study or comparative clinical endpoint.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
FDA Class II recall Z-2767-2026 covers 3mensio Workstation versions 10.7 through 10.7 SP5 under specified Philips 3D echocardiography Color Doppler conditions. The FDA record states the issue was resolved in version 10.7 SP6; the recall remains open and classified in the reviewed record.
The firm initiated the correction on 2026-05-07. Under the specific affected configuration, measurements could be reported 0.8% to 34.4% larger than the actual anatomical dimension. FDA lists versions 10.7 through 10.7 SP5 as affected and states the issue was resolved in 10.7 SP6. Confirm installed versions and completion of the correction locally.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Vendor-independent CT, X-ray angiography, and two- or three-dimensional ultrasound data in DICOM format.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Imports DICOM from accessible file systems, local storage, CT systems, or PACS; results and images with overlays can be exported to network storage or PACS.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Available as a standalone Windows package or a web-based solution for network, on-premises, or cloud environments.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Advanced visualization, segmentation, cardiovascular measurements, calcium quantification, annotations, and reports for qualified-user review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Imports DICOM from accessible file systems, local storage, CT systems, or PACS; results and images with overlays can be exported to network storage or PACS.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
18Fields reviewed
6Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads
Recovered from the prior exact-submission extraction and normalized under the current provenance rules. The exact FDA decision summary and exact-submission recall record were manually reviewed. Commercial security, training, monitoring, pricing, and reimbursement remain separate verification tasks. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 1 postmarket candidate record; 1 has been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, fda device recall, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Care setting: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and does not state a care setting or patient population for the subject device. Confirm intended sites and patients with the vendor and local policy.
Limitations: Not publicly available - checked 2026-11-14 - Exact FDA submission
The exact FDA decision document was reviewed on 2026-11-14 and states no use limitation for the subject device beyond its indication. Confirm contraindications and labeled limits in the current labeling.
Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission
No public price or quote for the exact K250330 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Pie Medical Imaging CAAS reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No result was a vendor or payer page naming this product with coding or payment; any results were general billing guidance. This records what was found, not that none exists.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded search 2026-10-26: Pie Medical Imaging's only owning-domain policy page is a GDPR personal-data privacy notice (website/customer data scope, not product security); no product security statement located. Pie Medical Imaging states it is a fully owned Esaote Group subsidiary (recorded as a lead for a future Esaote-level bridge).
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-10-27 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: ADAS 3D post-processes contrast cardiac MRI and CTA to visualize and quantify myocardial scar and export reviewed results to electrophysiology navigation systems; it is not intended to identify ablation targets.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: cvi42 analyzes cardiovascular CT and MRI with MPR, MIP, volume rendering, centerlines, lumen and stenosis measurements, and reporting for qualified professionals.
Modality
Radiological images; modality varies or is not specified in FDA list
Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.
Modality
Radiological images; modality varies or is not specified in FDA list
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.